Filter Results
Clinical Studies
Results filtered:Study status:
Open
Open
-
Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI) (SAMURAI)
Jacksonville, Fla.,
Rochester, Minn.
The purpose of this study is to determine whether the addition of stereotactic ablative radiotherapy (SABR) to the primary tumor in combination with immunotherapy improves outcomes compared to immunotherapy alone in patients with metastatic, unresected, renal cell carcinoma (RCC). The primary endpoint is nephrectomy and radiographic progression-free survival (nrPFS) with progression determined as per iRECIST criteria.
-
RELIEF: Randomized EvaLuation of the Impact of Empty Versus Full Bladder (RELIEF)
Rochester, Minn.,
Mankato, Minn.,
Jacksonville, Fla.,
La Crosse, Wis.,
Eau Claire, Wis.,
Scottsdale/Phoenix, Ariz.,
Albert Lea, Minn.
The purpose of this study is to determine whether an empty bladder during radiation therapy delivery for prostate cancer affects patient-reported urinary symptoms related to treatment.
.